iconstar paper   HBV Articles  
Back grey arrow rt.gif
 
 
A Phase 2 Study of Lonafarnib, Ritonavir & Peginterferon Lambda for 24 Weeks: Interim End-of-Treatment Results from the LIFT HDV Study
 
 
  https://www.natap.org/2019/AASLD/AASLD_67.htm

Summary

  
 
 
 
  iconpaperstack View Older Articles   Back to Top   www.natap.org